<code id='08DB223B6C'></code><style id='08DB223B6C'></style>
    • <acronym id='08DB223B6C'></acronym>
      <center id='08DB223B6C'><center id='08DB223B6C'><tfoot id='08DB223B6C'></tfoot></center><abbr id='08DB223B6C'><dir id='08DB223B6C'><tfoot id='08DB223B6C'></tfoot><noframes id='08DB223B6C'>

    • <optgroup id='08DB223B6C'><strike id='08DB223B6C'><sup id='08DB223B6C'></sup></strike><code id='08DB223B6C'></code></optgroup>
        1. <b id='08DB223B6C'><label id='08DB223B6C'><select id='08DB223B6C'><dt id='08DB223B6C'><span id='08DB223B6C'></span></dt></select></label></b><u id='08DB223B6C'></u>
          <i id='08DB223B6C'><strike id='08DB223B6C'><tt id='08DB223B6C'><pre id='08DB223B6C'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:737
          Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

          WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

          The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

          advertisement

          But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition
          Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

          ChristineKao/STATTheFoodandDrugAdministration’sapprovalonFridayoftwogenetherapiesforsicklecelldiseas

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Neutralizing antibodies against HIV shows promise in children

          BuddingHIVvirions.NIAID/NIHWhenchildrenlivingwithHIVareinjectedwithneutralizingantibodies,thetreatme